NASDAQ:BCRX
BioCryst Pharmaceuticals Stock News
$4.57
+0.440 (+10.65%)
At Close: May 01, 2024
Top Ranked Momentum Stocks to Buy for April 20th
01:06pm, Monday, 20'th Apr 2020
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 20th
BioCryst call buyer realizes 101% same-day gains BCRX
12:39pm, Monday, 20'th Apr 2020
BioCryst call buyer realizes 101% same-day gains BCRX
Does BioCryst Pharmaceuticals (NASDAQ:BCRX) Have A Healthy Balance Sheet?
12:56pm, Saturday, 18'th Apr 2020
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
MAC, MRNA among premarket gainers
01:14pm, Friday, 17'th Apr 2020
AMC Entertainment Holdings (NYSE:AMC) +62% on liquidity boost.Genetic Technologies (NASDAQ:GENE) +30% on move into COVID-19 testing.Golden Bull (NASDAQ:DNJR) +28%.Tronox Holdings plc (NYSE:TROX) +19
36 Stocks Moving in Friday's Pre-Market Session
11:11am, Friday, 17'th Apr 2020
Gainers
electroCore, Inc. (NASDAQ: ECOR) shares rose 58.8% to $1.33 in pre-market trading after the director bought roughly 1.765 million shares at a price of $0.85 per share....
BioCryst's Galidesivir: A Promising Candidate Drug In The Race To COVID-19 Treatment
02:47pm, Thursday, 16'th Apr 2020
Finally, after several days and weeks waiting for news, last Thursday, April 9, the company reported the start of the trial with Galidesivir in patients with CO
BioCryst (BCRX) Gets a Hold Rating from Needham
09:27am, Thursday, 16'th Apr 2020
In a report released today, Serge Belanger from Needham maintained a Hold rating on BioCryst (BCRX). The company's shares closed last Wednesday at $2.70.
Are Options Traders Betting on a Big Move in BioCryst Pharmaceuticals (BCRX) Stock?
01:36pm, Wednesday, 15'th Apr 2020
Investors need to pay close attention to BioCryst Pharmaceuticals (BCRX) stock based on the movements in the options market lately.
Are Options Traders Betting on a Big Move in BioCryst Pharmaceuticals (BCRX) Stock?
01:36pm, Wednesday, 15'th Apr 2020
Investors need to pay close attention to BioCryst Pharmaceuticals (BCRX) stock based on the movements in the options market lately.
BioCryst Pharmaceuticals (NASDAQ:BCRX) Lifted to Hold at BidaskClub
07:44am, Wednesday, 15'th Apr 2020
BioCryst Pharmaceuticals (NASDAQ:BCRX) was upgraded by research analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued on Wednesday, BidAskClub reports. A n
BioCryst Latest to Enter Covid-19 Battle
10:29pm, Tuesday, 14'th Apr 2020
Small pharma company testing antiviral drug in Brazil Continue reading...
BioCryst Latest to Enter Covid-19 Battle
09:45pm, Tuesday, 14'th Apr 2020
BioCryst Latest to Enter Covid-19 Battle, Stocks: BCRX,TSE:4551, release date:Apr 14, 2020
Birmingham work will support new clinical trial for COVID-19 treatment
06:32pm, Tuesday, 14'th Apr 2020
BioCryst Pharmaceuticals is beginning a trial to see if its primary anti-viral drug can fight COVID-19.
Remdesivir Success Will Trigger BioCryst Surge
02:49pm, Tuesday, 14'th Apr 2020
BCRX's berotralstat (BCX7353) is an orally active bradykinin inhibitor currently under review in Japan, the U.S., and Europe for the treatment of hereditary ang
Man Group plc Purchases Shares of 24,300 BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
10:36am, Tuesday, 14'th Apr 2020
Man Group plc purchased a new stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchas
